Screening of natural products for therapeutic activity against solid tumors |
| |
Authors: | El-Menshawi Bassem S Fayad Walid Mahmoud Khaled El-Hallouty Salwa M El-Manawaty May Olofsson Maria Hägg Linder Stig |
| |
Affiliation: | Department of Pharmacognosy, Pharmaceutical Sciences Division, National Research Centre, Dokki, Giza 12622, Egypt. |
| |
Abstract: | Most of the currently used cancer therapeutics are natural products. These agents were generally discovered based on their toxicity to tumour cells using various bioassays. Although the exact mechanisms of action of the most commonly used cancer therapeutics such as anthracyclins, podophyllotoxins and camptothecin are incompletely understood, it is becoming increasingly clear that these agents often show complex modes of action at the cellular level, interacting with numerous targets. Such complex modes of action may be the very reason for clinical efficacy. For discovering new cytotoxic anticancer drugs sophisticated screening methods were used. The principles of such screening projects conducted, using collections of purified natural products or extracts from plants have been described. By performing simple but robust prescreening tests such as the brine shrimp assay, bioactive extracts can be identified. Extracts (65) prepared from a collection of Egyptian plants were identified that showed cytotoxity on HepG2 cells. Interestingly, 22 (33%) of these raw extracts, induced > 2-fold induction of caspase-cleavage activity in a colon carcinoma cell line, consistent with induction of apoptosis. Only a fraction of the diversity of the biosphere has been tested for biological activity and novel cancer therapeutics remains to be discovered. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|